Research Article
Prognostic Role of Nucleosomes Containing Histones of the H3.1 Type in Septic Shock: Results of a Prospective Study
Issue:
Volume 12, Issue 5, October 2026
Pages:
82-95
Received:
31 May 2026
Accepted:
13 July 2026
Published:
23 October 2026
Abstract: Cell-free DNA (cfDNA) and neutrophil extracellular traps (NETs), specifically marked by histone type 3.1, play a dual pathogenic role in sepsis by reflecting cellular damage and directly exacerbating tissue injury, highlighting their clinical relevance for extracorporeal elimination therapies. To evaluate their prognostic value, we conducted a prospective, single-center observational study quantifying nucleosomes containing histones of the H3.1 type (Nu.H3.1) in 52 adult patients with septic shock admitted to an intensive care unit between August 2023 and May 2024. The cohort (64% male) had a mean SOFA score of 10±4 and an APACHE II score of 22±7. The H3.1-nuc concentration was 4658 ± 3962 ng/mL, and the median cfDNA level was 3041 (876–7815) ng/mL. Statistical analysis revealed that Nu.H3.1 levels significantly and positively correlated with cfDNA (r=0.67; p=0.0001), serum lactate (r=0.4; p=0.004), and SOFA scores (r=0.41; p=0.002). Furthermore, Nu.H3.1 demonstrated significant predictive performance for both 28-day mortality (AUC=0.68; 95% CI: 0.53–0.84; p=0.037) and the development of acute kidney injury (AKI) (AUC=0.74; 95% CI: 0.57–0.90; p=0.014). In conclusion, Nu.H3.1 serves as an independent predictor of adverse outcomes in septic shock, with established threshold values identifying patients at high risk for mortality and AKI. These findings suggest that Nu.H3.1 is a promising biomarker for clinical risk stratification and for substantiating indications for the extracorporeal elimination of toxic DNA-associated structures from the systemic circulation.
Abstract: Cell-free DNA (cfDNA) and neutrophil extracellular traps (NETs), specifically marked by histone type 3.1, play a dual pathogenic role in sepsis by reflecting cellular damage and directly exacerbating tissue injury, highlighting their clinical relevance for extracorporeal elimination therapies. To evaluate their prognostic value, we conducted a pros...
Show More
Research Article
Diagnostic Relevance of Prostate-Specific Antigen and Membrane Antigen Levels in Male Smokers and Nonsmokers in Port Harcourt, Nigeria
Osiagor Josephine,
Wariboko Anthony Hellen
,
Brown Holy*
Issue:
Volume 12, Issue 5, October 2026
Pages:
96-102
Received:
19 October 2026
Accepted:
2 November 2026
Published:
19 November 2026
DOI:
10.11648/j.ijcems.20261205.12
Downloads:
Views:
Abstract: Prostate cancer remains a significant global public health concern, including in Nigeria, where increasing incidence and late- stage presentation have been reported in urban centres such as Port Harcourt. This study compared prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) levels among male smokers and non-smokers in Port Harcourt, Nigeria, to assess their diagnostic relevance and the influence of lifestyle factors. A comparative cross-sectional design was employed, involving 180 male participants aged 40–60 years: 90 smokers and 90 non-smokers recruited through convenience sampling. Data were collected using structured questionnaires covering demographic and lifestyle variables. We collected, processed, and analysed venous blood samples (5 mL) for PSA and PSMA levels using sandwich enzyme-linked immunosorbent assay (ELISA) techniques. Statistical analyses were performed using GraphPad Prism version 8.02. We compared groups using one-way ANOVA and post hoc tests, with statistical significance set at p < 0.05. We also performed receiver operating characteristic (ROC) curve analysis to evaluate diagnostic performance. The results showed that smokers had significantly higher mean PSA (4.48 ± 1.082 ng/mL) and PSMA (4.00 ± 1.628 ng/mL) levels than non- smokers (PSA: 1.98 ± 0.298 ng/mL; PSMA: 1.88 ± 0.145 ng/mL), with p- values of 0.0003 and < 0.0001, respectively. ROC analysis showed that PSMA had superior diagnostic performance (AUC = 0.766) than PSA (AUC = 0.634). Alcohol consumption was also significantly associated with elevated PSA and PSMA levels, whereas exercise had a significant but variable effect. Age influenced biomarker levels in specific groups, while smoking intensity and duration showed weak, non- significant correlations with both markers. In conclusion, smoking was associated with elevated prostate biomarkers, suggesting an increased risk of prostate dysfunction. PSMA showed greater diagnostic capability than PSA, suggesting it may be a more reliable biomarker for early detection. Integrating both biomarkers with lifestyle interventions may strengthen prostate cancer screening and prevention strategies.
Abstract: Prostate cancer remains a significant global public health concern, including in Nigeria, where increasing incidence and late- stage presentation have been reported in urban centres such as Port Harcourt. This study compared prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) levels among male smokers and non-smokers in Po...
Show More